Pere Puigserver, Ph.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Pere Puigserver, Ph.D., Dana-Farber Cancer Institute

Caption

Scientists at Dana-Farber Cancer Institute have discovered why diabetic-like symptoms develop in some patients given rapamycin, an immune-suppressant drug that also has shown anti-cancer activity and may even slow aging.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.